Norgestimate And Ethinyl Estradiol Kit
Product Images NDC 72789-434

6 FDA label images from Pd-rx Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Norgestimate And Ethinyl Estradiol (NDC 72789-434). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Image 1)

1 (Image 1)
A horizontal forest plot chart showing effect estimates from various studies comparing Ever Combined Oral Contraceptive (COC) use vs. Never COC use, and Current COC use vs. Never use. Study names and dates are listed on the left, with corresponding confidence intervals and odds ratios, risk ratios, or hazard ratios on the right. The x-axis measures effect estimate from -1.50 to 2.00.*
FDA Label Image

2 (Image 2)

2 (Image 2)
Chemical structure of Norgestimate, showing its molecular framework with labeled functional groups. The structure includes cyclic components and specific atoms such as methyl groups and acetyl groups, consistent with the steroidal composition of Norgestimate.*
FDA Label Image

3 (Image 3)

3 (Image 3)
Chemical structure diagram of Ethinyl Estradiol, USP, showing its molecular framework with labeled hydroxyl (OH) and methyl (CH3) groups, as well as a triple-bonded carbon group.*
FDA Label Image

4 (Image 4)

4 (Image 4)
A vertical effectiveness chart comparing pregnancy rates per 100 women in one year across various birth control methods. It ranks methods from 'Fewer than 1 pregnancy' (implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring) to '85 or more pregnancies' (no birth control), highlighting use-effectiveness.*
FDA Label Image

5 (Image 5)

5 (Image 5)
The image shows a Blister pack of Sprintec with Norgestimate and Ethinyl Estradiol tablets USP, 0.250 mg/0.035 mg. It is arranged in a 28-day cycle with pills organized by days of the week and weeks numbered 1 through 4. The pack includes colored pills for the first three weeks and white pills for the fourth week, indicating a combination oral contraceptive. The label instructs to take all colored pills before any white pills and specifies storage at 20° to 25°C. The labeler is PD-Rx Pharmaceuticals, Inc.*
FDA Label Image

72789434 Label (72789434)

72789434 Label (72789434)
Norgestimate and Ethinyl Estradiol 0.250mg/0.035mg 28 tablets kit label by PD-Rx Pharmaceuticals, Inc. The label includes the product NDC 72789-434-79, batch lot 10005476, and expiration date 04/2025. Usage instructions and warnings about keeping out of reach of children are displayed, along with reorder number 111613 and manufacturer contact information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.